Antithrombin

From Proteopedia
Revision as of 14:22, 22 February 2016 by Michal Harel (talk | contribs)
Jump to navigation Jump to search


Function

Antithrombin (AT) inactivates several enzymes of the coagulation cycle. AT is relatively inactive until it binds the heparan sidechains of the microvasculature.[1]

α-AT contains 4 occupied glycosylation sites and is found in blood palsma.
β-AT contains only 3 occupied glycosylation sites.
AT-I refers to the absorption of thrombin to fibrin.
AT-II and heparin interfere with the interaction of thrombin and fibrinogen.
AT-III inactivates thrombin in plasma. For details see Student Projects for UMass Chemistry 423 Spring 2012-7.
AT-IV becomes activated during blood coagulation.
See details for the antithrombin pentasaccharide complex in Molecular Playground/Antithrombin-Heparin.

Disease

AT deficiency diseases are: Acquired AT deficiency and Inherited AT deficiency. AT deficiency is involved in thrombosis and pulmonary embolism.

Relevance

AT activity is enhanced upon .

Structural highlights

The binding of AT to the heparans or the heparin drug is to a core pentasaccharide. The binding induces conformational change of AT.

Glycosylated human antithrombin III complex with heparin (in green) (PDB code 3evj)

Drag the structure with the mouse to rotate

3D structures of antithrombin3D structures of antithrombin

Updated on 22-February-2016

ReferencesReferences

  1. Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004 Sep;11(9):857-62. Epub 2004 Aug 15. PMID:15311269 doi:10.1038/nsmb811

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky